Making Liver Disease Relevant to a Global Audience/Non-hepatologist Audience
Melina I Manolas, MD, MPH, Presenter
Acute Liver Failure
Acute-on-Chronic Liver Failure
ALD
Cirrhosis and Portal Hypertension
Drug-Induced Liver Injury
Hepatitis
Liver Cancer
MASLD
10:07 AM - 10:42 AM
Nov
09
2025
Washington, D.C.
Panel Discussion
Tamar H Taddei, MD, MD, FAASLD, Moderator
Acute Liver Failure
Acute-on-Chronic Liver Failure
ALD
Cirrhosis and Portal Hypertension
Drug-Induced Liver Injury
Hepatitis
Liver Cancer
MASLD
10:42 AM - 10:45 AM
Nov
09
2025
Washington, D.C.
Closing
Mazen Noureddin, MD, MHSc, Moderator
Acute Liver Failure
Acute-on-Chronic Liver Failure
ALD
Cirrhosis and Portal Hypertension
Drug-Induced Liver Injury
Hepatitis
Liver Cancer
MASLD
Objectives
At the end of this session, attendees will be able to describe the global burden of
liver disease and explain why it is underdiagnosed.
Attendees will be able to describe ways that liver disease could be elevated as a
priority with a non-hepatologist audience, including primary care providers.
Discuss ways hepatology providers can facilitate the early recognition of liver
disease in the community.